Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.377,64
0,56%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Bausch plus Lomb Corporation (BLCO) Bausch plus Lomb Corporation (BLCO) Notizie

Bausch plus Lomb Corporation

BLCO
15,09
0,22 (1,48%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/6/202413:00BWBausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel..
03/6/202413:00BWBausch + Lomb Launches Blink™ NutriTears® Clinically Proven..
29/5/202422:44EDGAR2Form 8-K - Current report
29/5/202422:30BWBausch + Lomb Announces 2024 Annual Meeting of Shareholder..
28/5/202415:00BWBausch + Lomb Announces Presentation of New Scientific Data..
28/5/202412:59BWBausch + Lomb Receives Health Canada Approval for enVista®..
07/5/202415:09IHMARKETNEWSFutures Pointing To Roughly Flat Open On Wall Street
06/5/202422:34IHMARKETNEWSU.S. Stocks See Further Upside Amid Renewed Interest Rate..
01/5/202412:58BWBausch + Lomb Announces First-Quarter 2024 Results
29/4/202413:00BWBausch + Lomb Announces Presentation of New Data at the..
25/4/202414:30BWBausch + Lomb Announces Statistically Significant Results..
18/4/202413:00BWBausch + Lomb Reports More Than 84 Million Units of Contact..
15/4/202418:00BWBausch + Lomb Will Release First-Quarter 2024 Financial..
27/3/202412:00BWBausch + Lomb Will Present New Scientific Data and Analyses..
04/3/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202414:12EDGAR2Form 8-K - Current report
28/2/202414:00BWBausch + Lomb Announces Appointment of Karen L. Ling to..
21/2/202413:00EDGAR2Form 8-K - Current report
21/2/202413:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
21/2/202412:58BWBausch + Lomb Announces Fourth-Quarter and Full-Year 2023..
05/2/202418:00BWBausch + Lomb Will Release Fourth-Quarter and Full-Year 2023..
08/1/202412:59BWBausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser..
03/1/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:00BWBausch + Lomb to Participate in the 42nd Annual J.P. Morgan..
15/11/202312:59BWBausch + Lomb Reports More Than 76 Million Units of Contact..
13/11/202322:47EDGAR2Form 8-K/A - Current report: [Amend]
07/11/202323:00EDGAR2Form 8-K/A - Current report: [Amend]
01/11/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202312:02EDGAR2Form 8-K - Current report
01/11/202311:58BWBausch + Lomb Announces Third-Quarter 2023 Results and..
26/10/202312:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
16/10/202318:00BWBausch + Lomb Will Release Third-Quarter 2023 Financial..
04/10/202312:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
03/10/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:24EDGAR2Form 8-K - Current report
29/9/202316:00BWBausch + Lomb Completes Acquisition of XIIDRA®
26/9/202312:59BWBausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the..
20/9/202312:59BWBausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling..
14/9/202323:26EDGAR2Form 8-K - Current report
14/9/202323:25BWBausch + Lomb Announces Pricing of Senior Secured Notes..
12/9/202312:59BWBausch + Lomb Launches MIEBO™ (Perfluorohexyloctane..
11/9/202313:22EDGAR2Form 8-K - Current report
11/9/202313:07BWBausch + Lomb Announces Launch of Proposed Financing for..
06/9/202323:58BWBausch + Lomb Announces Disclosure of Historical and Pro..
Apertura: 14,69 Min: 14,69 Max: 15,11
Chiusura: 14,87

La tua Cronologia

NYSE
BLCO
Bausch plus Lomb
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network